» Authors » Cira Buonfantino

Cira Buonfantino

Explore the profile of Cira Buonfantino including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 165
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallo A, Di Spiezio Sardo A, Conforti A, Iorio G, Zizolfi B, Buonfantino C, et al.
Reprod Biomed Online . 2024 Mar; 48(5):103750. PMID: 38430660
Research Question: Is ovarian stimulation with levonorgestrel intrauterine system (LNG-IUS) in situ and co-treatment with letrozole safe and effective in patients undergoing fertility-sparing combined treatment for atypical endometrial hyperplasia (AEH)...
2.
Giampaolino P, Mercorio A, Serafino P, Iorio G, Buonfantino C, Bifulco G, et al.
Fertil Steril . 2023 Jun; 120(3 Pt 2):701-702. PMID: 37302780
Objective: To describe a feasible fertility preservation strategy in a woman with vaginal carcinoma. Design: Video case report demonstrating the diagnostic work-up and laparoscopic oocyte retrieval performed under regional anesthesia....
3.
Mercorio A, Della Corte L, Boccia D, Palumbo M, Reppuccia S, Buonfantino C, et al.
Front Surg . 2023 May; 10:1151901. PMID: 37139194
Adhesion formation following gynecological surgery remains a challenge. The adoption of minimally invasive surgical approaches, such as conventional or robotic-assisted laparoscopy combined with meticulous microsurgical principles and the application of...
4.
Sirico A, Carbone L, Avino L, Buonfantino C, De Angelis M, Cresce M, et al.
J Clin Med . 2022 Nov; 11(21). PMID: 36362731
Background: Since there is no available data on temporal trends of caesarean section (CS) rates in pregnant women with COVID-19 through the pandemic, we aimed to analyze the trends in...
5.
Giampaolino P, Cafasso V, Boccia D, Ascione M, Mercorio A, Viciglione F, et al.
Biomed Res Int . 2022 Oct; 2022:4070368. PMID: 36203482
Background: Endometrial cancer (EC) is one of the most common gynecologic malignancy, mostly in postmenopausal women. The gold standard treatment for EC is surgery, but in the early stages, it...
6.
Della Corte L, Mercorio A, Serafino P, Viciglione F, Palumbo M, De Angelis M, et al.
Front Surg . 2022 Sep; 9:973034. PMID: 36081590
Borderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. In 80% of cases the diagnosis of BOTs is done at stage I and more than a...
7.
Mercorio A, Della Corte L, De Angelis M, Buonfantino C, Ronsini C, Bifulco G, et al.
Medicina (Kaunas) . 2022 Aug; 58(8). PMID: 36013469
Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility. The complex metabolic dysregulation at the base of this syndrome often renders infertility management challenging. Many pharmacological strategies have...
8.
Iorio G, Carbone L, Donadono V, Rovetto M, Sarno L, Saccone G, et al.
Minerva Obstet Gynecol . 2022 Apr; 74(2):171-177. PMID: 35421917
Introduction: Hormonal changes during pregnancy may induce modifications in oral mucosa. Epulis gravidarum (EG) is an oral disease arising during pregnancy, usually regressing after delivery. A case of EG managed...
9.
Carbone L, Conforti A, La Marca A, Cariati F, Vallone R, Raffone A, et al.
Minerva Obstet Gynecol . 2021 Jun; 74(1):83-106. PMID: 34137567
Infections may act with variable impact on the physiopathology of the reproductive organs, determining infertility or reducing the outcomes of assisted reproduction technology. The aim of this narrative review is...
10.
Giampaolino P, Foreste V, Di Filippo C, Gallo A, Mercorio A, Serafino P, et al.
Int J Mol Sci . 2021 Mar; 22(4). PMID: 33669557
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease. The hypothesis that alterations in the microbiome are involved in the genesis of PCOS has been postulated. Aim of...